The oncology market is playing an inevitable role worldwide with its latest innovation offering solutions for fatal diseases. Also, the rapidly rising R&D activities and surging investments, coupled with the adoption of cutting-edge technologies are propelling the growth and development of the market.
Given the industry's rosy prospects, it could be wise to invest in fundamentally strong biotech stocks Pyxis Oncology, Inc. (PYXS), Immatics N.V. (IMTX), and Jazz Pharmaceuticals plc (JAZZ) poised for major upside.
